Based in Ahmedabad, India, CPL Biologicals Pvt. Ltd. is a joint-venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, one of India's largest privately held pharmaceutical companies. CPL Biologicals has a three pronged approach to providing novel, affordable solution for global healthcare - vaccines, biologics and diagnostics, with integrated capabilities from early stage research and development to clinical and commercial manufacturing along with dedicated sales and marketing teams. CPL Biologicals has established state-of-the-art R&D and manufacturing facilities in Dholka, Gujarat (India), which currently has the capability of producing up to 25 million doses every year.
CPL Biologicals aims to be a leading provider of high quality, affordable vaccines, biologics and diagnostics through world-class research and innovations combined with cost effective and efficient manufacturing to address current and future global health challenges.